Internal Medicine, Nephrology · Winfield, IL
NPI
1891074555
Since 2011
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
25 N. Winfield Rd., Ste 405
Winfield, IL, 60190
Phone (630) 873-8889
Groups this clinician bills Medicare through
Medicare paid, 2024
$144K
3,334 services
Medicare patients, 2024
393
Average age 76
Drug cost, 2024
$323K
1,588 prescriptions
Company payments, 2025
$380
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ankit Rawal was code 99233 (hospital e&m - subsequent), 573 times for 182 patients. In total Ankit Rawal billed 3,334 services in 52 codes, and Medicare paid $144K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-08-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 573 | 182 | $95.48 | $55K |
| 36415 Venipuncture Blood Collection | Office | 247 | 117 | $8.65 | $2,137 |
| 99214 Office E&M - Established | Office | 170 | 129 | $90.40 | $15K |
| 99223 Hospital E&M - Initial | Facility | 146 | 122 | $137.45 | $20K |
| 80048 Clinical Chemistry | Office | 144 | 96 | $8.29 | $1,194 |
| 85025 Blood Count | Office | 113 | 65 | $7.61 | $860 |
| 82570 Clinical Chemistry | Office | 105 | 71 | $5.08 | $533 |
| 82043 Clinical Chemistry | Office | 73 | 59 | $5.66 | $413 |
| 80069 Clinical Chemistry | Office | 68 | 33 | $8.51 | $579 |
| 99215 Office E&M - Established | Office | 63 | 35 | $138.14 | $8,703 |
| 83970 Clinical Chemistry | Office | 52 | 33 | $40.45 | $2,103 |
| 82306 Clinical Chemistry | Office | 52 | 40 | $29.01 | $1,509 |
| 85027 Blood Count | Office | 48 | 26 | $6.34 | $304 |
| 82728 Clinical Chemistry | Office | 44 | 29 | $13.36 | $588 |
| 84156 Clinical Chemistry | Office | 43 | 37 | $3.60 | $155 |
By year: 2022 $164K for 4,682 services; 2023 $152K for 4,127 services; 2024 $144K for 3,334 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 247 | 117 | $8.65 | $2,137 |
| 80048 Clinical Chemistry | 144 | 96 | $8.29 | $1,194 |
| 85025 Blood Count | 113 | 65 | $7.61 | $860 |
| 82570 Clinical Chemistry | 105 | 71 | $5.08 | $533 |
| 82043 Clinical Chemistry | 73 | 59 | $5.66 | $413 |
| 80069 Clinical Chemistry | 68 | 33 | $8.51 | $579 |
| 82306 Clinical Chemistry | 52 | 40 | $29.01 | $1,509 |
| 83970 Clinical Chemistry | 52 | 33 | $40.45 | $2,103 |
| 85027 Blood Count | 48 | 26 | $6.34 | $304 |
| 82728 Clinical Chemistry | 44 | 29 | $13.36 | $588 |
Medicare prescription drug claims, 2024
In 2024, the drug Ankit Rawal prescribed most often to Medicare patients was Amlodipine Besylate, with 164 prescriptions and refills. In total Ankit Rawal wrote 1,588 Medicare prescriptions that cost $323K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 164 | 429 | 55 | $1,106 |
| Carvedilol Generic | 114 | 306 | 38 | $1,168 |
| Calcitriol Generic | 109 | 296 | 32 | $1,668 |
| Torsemide Generic | 82 | 221 | 28 | $1,233 |
| Hydralazine Hcl Generic | 79 | 205 | 32 | $970 |
| Furosemide Generic | 75 | 172 | 24 | $417 |
| Jardiance Empagliflozin | 64 | 86 | 18 | $49K |
| Losartan Potassium Generic | 64 | 176 | 25 | $775 |
| Indapamide Generic | 56 | 159 | 19 | $717 |
| Chlorthalidone Generic | 56 | 168 | 21 | $662 |
| Clonidine Hcl Generic | 53 | 120 | 17 | $457 |
| Olmesartan Medoxomil Generic | 51 | 134 | 17 | $824 |
| Farxiga Dapagliflozin Propanediol | 48 | 89 | 13 | $50K |
| Allopurinol Generic | 47 | 140 | 15 | $1,818 |
| Bumetanide Generic | 39 | 105 | 14 | $1,270 |
Brand drugs: - claims; generic drugs: 1,410 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ankit Rawal $380 ($380 in general payments such as food, travel and fees) from 9 companies. The largest payer was Otsuka America Pharmaceutical, Inc. with $92.05.
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. 4578.T | 4 | $92.05 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $73.55 |
| Travere Therapeutics, Inc. TVTX | 2 | $50.7 |
| Vifor Pharma, Inc. | 2 | $45.04 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $27.75 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $27.02 |
| Ardelyx, Inc. ARDX | 1 | $24.12 |
| Amgen Inc. AMGN | 1 | $23.17 |
| Calliditas Therapeutics US Inc. | 1 | $16.99 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.